233 related articles for article (PubMed ID: 16515971)
21. Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.
Zhang L; Hannay JA; Liu J; Das P; Zhan M; Nguyen T; Hicklin DJ; Yu D; Pollock RE; Lev D
Cancer Res; 2006 Sep; 66(17):8770-8. PubMed ID: 16951193
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.
Mylona E; Magkou C; Gorantonakis G; Giannopoulou I; Nomikos A; Zarogiannos A; Zervas A; Nakopoulou L
Anticancer Res; 2006; 26(5A):3567-71. PubMed ID: 17094484
[TBL] [Abstract][Full Text] [Related]
23. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
24. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
25. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
Guo ZH; Mei H; Huang J; Li SY
Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
[TBL] [Abstract][Full Text] [Related]
26. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
Chen H; Ye D; Xie X; Chen B; Lu W
Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
28. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.
Herrmann E; Eltze E; Bierer S; Köpke T; Görge T; Neumann J; Hertle L; Wülfing C
Anticancer Res; 2007; 27(5A):3127-33. PubMed ID: 17970053
[TBL] [Abstract][Full Text] [Related]
29. Chemo-angiogenic profile of bovine urinary bladder tumors distinguishes urothelial carcinomas from hemangiosarcomas.
Carvalho T; Elias AP; Nunes T; Peleteiro MC; Dias S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):344-58. PubMed ID: 18022698
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
32. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.
Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M
Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.
Zu X; Tang Z; Li Y; Gao N; Ding J; Qi L
BJU Int; 2006 Nov; 98(5):1090-3. PubMed ID: 17034609
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
35. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
Oliveira-Ferrer L; Tilki D; Ziegeler G; Hauschild J; Loges S; Irmak S; Kilic E; Huland H; Friedrich M; Ergün S
Cancer Res; 2004 Dec; 64(24):8932-8. PubMed ID: 15604255
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria.
Aucejo F; Kim R; Zein N; Quintini C; Uso TD; Lopez R; Eghtesad B; Fung J; Miller C; Yerian L
Liver Transpl; 2009 Feb; 15(2):169-76. PubMed ID: 19177438
[TBL] [Abstract][Full Text] [Related]
37. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.
Qi L; Robinson WA; Brady BM; Glode LM
Anticancer Res; 2003; 23(5A):3917-22. PubMed ID: 14666697
[TBL] [Abstract][Full Text] [Related]
38. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Chung GG; Yoon HH; Zerkowski MP; Ghosh S; Thomas L; Harigopal M; Charette LA; Salem RR; Camp RL; Rimm DL; Burtness BA
Cancer; 2006 Apr; 106(8):1677-84. PubMed ID: 16532435
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
